about IAS-USA
news and events
cme programs
course registration
Cases on the Web
publications/guidelines
guidelines
Oral Manifestations Resource Card
Dermatologic Manifestations of HIV
Drug Resistance Mutations
Webcast and Podcasts
board and staff core faculty
fdd
donations
contact
home

July 23, 2010: Now Available Online: Webcasts and Podcasts of the Atlanta, GA (March 2, 2010), Los Angeles, CA (March 10, 2010), New York, NY, (March 22, 2010), Chicago, IL (April 19, 2010), San Francisco, CA (May 17, 2010), and Washington, DC (June 17, 2010) Web-based CME Meetings. These activities have been approved for AMA PRA Category 1 Credit™.
July 19, 2010: The Antiretroviral Guidelines Panel of the International AIDS Society–USA has released updated treatment guidelines for HIV-infected adults that focus on preventing the progression of HIV infection to AIDS. These findings highlight the importance of initiating antiretroviral therapy early, even in asymptomatic patients. The updates are available in the July 21, 2010 issue of the Journal of the American Medical Association. This article can also be accessed, free of charge, on the JAMA Web site, at http://jama.ama-assn.org. For more information, click here.
July 14, 2010: REGISTRATION IS NOW CLOSED for 2010 Annual Clinical Conference for the Ryan White HIV/AIDS Program, Part A, B, C, and D. For program information, please click here.
July 8, 2010: John P. Phair, MD, Professor of Medicine, Emeritus, Northwestern University Medical School, Chicago, IL, is honored as the first recipient of the IAS–USA Lifetime of Leadership Award for his admirable and lasting contributions to the field of HIV medicine and research. Click here for more details.
May 21, 2010: Registration for Fall New York is now open. Early registration is strongly recommended; the early registration fee is $65. The new on-site registration fee is $130. Click here for more details.
 


Welcome




© Copyright 2010. International AIDS Society-USA. All rights reserved.
Use of this site is subject to the Visitor's Agreement and Privacy and Confidentiality Policy.
Please read them carefully.